A pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma

被引：0
|
作者：
F. Mühr-Wilkenshoff
W. Hinkelbein
I. Ohnesorge
K. J. Wolf
E.-O. Riecken
M. Zeitz
H. Scherübl
机构：
[1] University Hospital Benjamin Franklin,Medical Clinic I
[2] University Hospital Benjamin Franklin,Department of Radiotherapy
[3] University Hospital Benjamin Franklin,Department of Radiology
来源：
International Journal of Colorectal Disease | 2003年 / 18卷
关键词：
Esophageal carcinoma; Irinotecan; CPT-11; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：330 / 334
页数：4
相关论文
共 50 条
  • [21] CPT-11/cisplatin neoadjuvant therapy downstages locally advanced gastric cancer
    Newman, E
    Marcus, SG
    Potmesil, M
    Hochster, H
    Yee, H
    Sewak, S
    Hayek, M
    Muggia, FM
    GASTROENTEROLOGY, 2001, 120 (05) : A129 - A129
  • [22] A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer
    Heather Wakelee
    George A. Fisher
    Investigational New Drugs, 2005, 23 : 241 - 242
  • [23] A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer
    Wakelee, H
    Fisher, GA
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (03) : 241 - 242
  • [24] Lower than standard doses of irinotecan (cpt-11) in the treatment of metastatic colorectal carcinoma (MCC)
    Nikolic-Tomasevic, Z
    Jelic, S
    Tomasevic, ZM
    Radulovic, S
    Radosavljevic, D
    Popov, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 305S - 305S
  • [25] CPT-11 is an active agent in patients with advanced gastric cancer.
    Köhne, CH
    Catane, R
    Klein, H
    Peretz, T
    Preusser, P
    Niederle, N
    Ducreux, M
    Wilke, H
    Jacques, C
    CLINICAL CANCER RESEARCH, 1999, 5 : 3773S - 3773S
  • [26] Irinotecan (CPT-11) in patients with advanced colon carcinoma relapsing after 5-fluorouracil-leucovorin combination
    Tsavaris, NB
    Polyzos, A
    Gennatas, K
    Kosmas, C
    Vadiaka, M
    Dimitrakopoulos, A
    Macheras, A
    Papastratis, G
    Tsipras, H
    Margaris, H
    Papalambros, E
    Giannopoulos, A
    Koufos, C
    CHEMOTHERAPY, 2002, 48 (02) : 94 - 99
  • [27] Phase I study of irinotecan (CPT-11) and capecitabine in combination with concurrent radiotherapy for locally advanced rectal cancer.
    Hofheinz, R
    Von Gerstenberg, B
    Wenz, F
    Gnad-Vogt, U
    Tiefenbacher, U
    Saussele, S
    Kreil, S
    Hochhaus, A
    Willeke, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 293S - 293S
  • [28] Irinotecan (CPT-11) pretreated metastatic colorectal cancer (CRC):: A single institution experience.
    Fernández, Y
    Lara, MA
    Salinas, P
    Alonso, ML
    García-Girón, C
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S12 - S12
  • [29] Irinotecan (CPT-11) as first line treatment of patients with not pretreated advanced colorectal cancer
    Firyida, JL
    Menendez, MD
    Mel, JR
    Diz, P
    Constenla-Figueiras, M
    Casal, J
    Valladares, M
    Castellanos, J
    Balcells, M
    ANNALS OF ONCOLOGY, 1998, 9 : 38 - 39
  • [30] A pilot study of irinotecan hydrochloride (CPT-11) plus cisplatin (CDDP) as salvage therapy for relapsed and refractory ATLL
    Fukushima, Takuya
    Yoshida, Shinichiro
    Hata, Tomoko
    Miyazaki, Yasushi
    Tsukasaki, Kunihiro
    Ikeda, Shuichi
    Tomonaga, Masao
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (04) : 630 - 631
12345